What are the admitting orders for a 10kg pediatric patient with Kawasaki disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Admitting Orders for Kawasaki Disease in a 10kg Pediatric Patient

Admit this 10kg child with Kawasaki disease to the hospital for immediate administration of IVIG 20 grams (2 g/kg) as a single infusion over 10 hours, combined with high-dose aspirin 800-1000 mg/day (80-100 mg/kg/day) divided into four doses every 6 hours. 1, 2

Immediate Treatment Orders

Primary Therapy

  • IVIG 20 grams (2 g/kg) IV as a single infusion over 10 hours - this is the cornerstone of treatment and should be initiated as soon as possible, ideally within the first 10 days of fever onset 1
  • Aspirin 250 mg PO every 6 hours (total 1000 mg/day = 100 mg/kg/day) - continue high-dose aspirin until patient is afebrile for 48-72 hours 1, 2
  • After fever resolves for 48-72 hours, reduce aspirin to 30-50 mg PO once daily (3-5 mg/kg/day) for antiplatelet effect 1

Monitoring Orders

  • Baseline echocardiogram - must be obtained at diagnosis to assess for coronary artery abnormalities 1, 2, 3
  • Continuous cardiac monitoring during IVIG infusion to detect potential adverse effects 1
  • Vital signs every 4 hours including temperature monitoring 1
  • Daily weights to assess fluid status 1

Laboratory Orders

  • Baseline labs before IVIG: CBC with differential, ESR, CRP, comprehensive metabolic panel (including albumin and transaminases), urinalysis 1
  • Repeat CRP and inflammatory markers 48 hours after IVIG completion to assess treatment response (note: ESR is less reliable after IVIG) 1
  • Follow-up echocardiogram at 1-2 weeks and 4-6 weeks after diagnosis 2, 4

Supportive Care Orders

Fluid Management

  • Maintenance IV fluids: D5 0.45% NaCl at 40 mL/hour (using 4-2-1 rule: 40 mL/hr for first 10kg) - run concurrently with IVIG infusion 1
  • Monitor for fluid overload during IVIG administration, particularly watching for signs of congestive heart failure 5

Activity and Diet

  • Bedrest during acute febrile phase 1
  • Regular diet as tolerated - encourage oral hydration 1
  • NPO 4 hours before IVIG if patient has nausea or vomiting risk 1

Precautions

  • Standard precautions - Kawasaki disease is not contagious 1
  • Fall precautions due to potential irritability and weakness 1

Anticipatory Management

IVIG Resistance Protocol

  • If fever persists or recurs ≥36 hours after completing IVIG infusion, prepare for second dose of IVIG 20 grams (2 g/kg) as single infusion 6, 2, 7
  • Do not advance to corticosteroids unless fever persists after two doses of IVIG 6, 2
  • Continue high-dose aspirin throughout any retreatment 1

Adverse Effect Monitoring

  • Watch for IVIG-related adverse effects: headache, fever, chills, myalgias (occur in approximately 2.7% of patients) 5
  • Monitor for new or worsening heart failure during infusion - this is the most serious potential complication 5
  • Acetaminophen 150 mg PO/IV every 6 hours PRN for fever or discomfort during IVIG infusion 1
  • Avoid ibuprofen - it antagonizes aspirin's antiplatelet effects 1, 2

Long-Term Considerations

Immunization Hold

  • Document that measles and varicella vaccines must be deferred for 11 months after high-dose IVIG administration 1, 2
  • Order annual influenza vaccine for this patient who will be on long-term aspirin therapy 1, 2, 7

Aspirin Duration

  • If no coronary abnormalities on follow-up echocardiograms: continue low-dose aspirin until 6-8 weeks after disease onset 1, 2, 7
  • If coronary abnormalities develop: continue low-dose aspirin indefinitely 1, 2
  • If moderate aneurysms (4-6 mm) develop: add clopidogrel to aspirin 1
  • If giant aneurysms (≥8 mm) develop: add warfarin (target INR 2.0-3.0) or LMWH to aspirin 1

Critical Pitfalls to Avoid

  • Do not delay IVIG waiting for all diagnostic criteria to be met if clinical suspicion is high - incomplete Kawasaki disease still requires treatment 1, 2
  • Do not skip the second IVIG dose and jump to corticosteroids for IVIG resistance - this violates established protocols 6
  • Do not assume aspirin alone is adequate - aspirin does not prevent coronary abnormalities and is only adjunctive therapy 6
  • Do not use ibuprofen for fever control in patients on aspirin therapy 1, 2
  • Infants under 1 year are at highest risk for coronary aneurysms despite having incomplete presentations - maintain high index of suspicion 1, 8

Discharge Planning

  • Cardiology follow-up within 1-2 weeks for repeat echocardiogram 2, 4
  • Primary care follow-up within 1 week of discharge 2
  • Parent education regarding aspirin administration, Reye's syndrome risk with influenza/varicella exposure, and signs of cardiac complications 1
  • Activity restrictions until cleared by cardiology based on coronary artery status 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kawasaki disease: State of the art.

Congenital heart disease, 2017

Guideline

Treatment of IVIG-Resistant Kawasaki Disease with Cardiac Involvement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kawasaki disease: contemporary perspectives.

The Lancet. Child & adolescent health, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.